Evidence map›Paper›PMID 35161622›Full record

ArticleSensors (Basel, Switzerland)2022

Automated Breast Cancer Detection Models Based on Transfer Learning.

Madallah Alruwaili, Walaa Gouda

Abstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Machine learning and new insights for breast cancer diagnosis.The Journal of international medical research · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. BCDiagnostics (Basel, Switzerland) · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Madallah AlruwailiCollege of Computer and Information Sciences, Jouf University, Sakaka 72341, Al Jouf, Saudi Arabia.
Walaa GoudaCollege of Computer and Information Sciences, Jouf University, Sakaka 72341, Al Jouf, Saudi Arabia.ORCID 0000-0001-6615-7658

Funding

Al Jouf University DSR-2021-02-0356
6 · The paper itself

Abstract

Breast cancer is among the leading causes of mortality for females across the planet. It is essential for the well-being of women to develop early detection and diagnosis techniques. In mammography, focus has contributed to the use of deep learning (DL) models, which have been utilized by radiologists to enhance the needed processes to overcome the shortcomings of human observers. The transfer learning method is being used to distinguish malignant and benign breast cancer by fine-tuning multiple pre-trained models. In this study, we introduce a framework focused on the principle of transfer learning. In addition, a mixture of augmentation strategies were used to prevent overfitting and produce stable outcomes by increasing the number of mammographic images; including several rotation combinations, scaling, and shifting. On the Mammographic Image Analysis Society (MIAS) dataset, the proposed system was evaluated and achieved an accuracy of 89.5% using (residual network-50) ResNet50, and achieved an accuracy of 70% using the Nasnet-Mobile network. The proposed system demonstrated that pre-trained classification networks are significantly more effective and efficient, making them more acceptable for medical imaging, particularly for small training datasets.

Indexed as

Breast NeoplasmsDisease ProgressionFemaleHumansMachine LearningMammographyNeural Networks, Computerbreast cancerdeep learningmammogrammedical imagingNasnet-MobileResNettransfer learning

Identifiers

PMID35161622
PMCPMC8838322

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.